Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | 1 | — | 1 | — | 3 |
Obstructive lung diseases | D008173 | — | — | — | 1 | — | 1 | — | 2 |
Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | — | 1 |
Communicable diseases | D003141 | — | — | — | — | — | 1 | — | 1 |
Dental focal infection | D005491 | — | — | — | — | — | 1 | — | 1 |
Focal infection | D005490 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Asthma | D001249 | EFO_0000270 | J45 | 3 | 1 | 1 | — | — | 5 |
Sinusitis | D012852 | EFO_0007486 | J32 | — | — | 1 | — | — | 1 |
Rhinosinusitis | D000096825 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bacterial infections | D001424 | — | A49 | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Etrolizumab |
INN | etrolizumab |
Description | Etrolizumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1743015 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | I2A72G2V3J (ChemIDplus, GSRS) |